//
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement
Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access?
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial
Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement